2018 HF Board Review Course

19 - Managing Immunosuppression and Drugs

Aug 18, 2018 10:15am ‐ Aug 18, 2018 10:45am


Credits: None available.


Speaker(s):

  • James Fang, MD, FHFSA, Professor of Medicine, University of Utah Health Sciences

Disclosures

  • James Fang, MD, FHFSA:
    • Consultant-Advisory Board- Novartis; Agmen; Capricor; Johnson & Johnson; AHA; NIH
    • Institution- University of Utah

Credits

  • 0.50 - CME
  • 0.50 - MOC

You must be logged in and own this session in order to post comments.